1-13 of 13
quinolines
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery of DNA G-Quadruplexes As a New Target for B-Cell Receptor Signaling Inhibition in Diffuse Large B-Cell Lymphoma

Ying-Zhi Xu, PhD, Thomas Raney, Samantha L. Kendrick, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3502.
https://doi.org/10.1182/blood-2018-99-116793
Published: 2018
Journal Articles

Targeting S100A9 Interactions in the Multiple Myeloma Bone Marrow Environment Reduces Angiogenesis and Tumor Growth

Kim De Veirman, PhD, Els Van Valckenborgh, PhD, Nathan De Beule, MD, Hendrik De Raeve, Ken Maes, PhD, Elke De Bruyne, PhD, Eline Menu, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2016) 128 (22): 3248.
https://doi.org/10.1182/blood.V128.22.3248.3248
Published: 2016
Journal Articles

Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Matko Kalac, MD PhD, Michael Mangone, PhD, Alison Rinderspacher, PhD, Shi-Xian Deng, PhD, Luigi Scotto, PhD, Jeremie Vendome, PhD, Mukesh Bansal, PhD, Andrea Califano, PhD, Donald Landry, MD PhD, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4435.
https://doi.org/10.1182/blood.V126.23.4435.4435
Published: 2015
Journal Articles

A Novel Agent Tasquinimod Demonstrates a Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma

Indu R Ramachandran, PhD, Cindy Lin, PhD, Tess Chase, Dmitry Gabrilovich, MD PhD, Yulia Nefedova, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5729.
https://doi.org/10.1182/blood.V124.21.5729.5729
Published: 2014
Journal Articles

MAGE-A Inhibits Apoptosis In Proliferating Multiple Myeloma Cells

Tricia Nardiello, BA, Achim A Jungbluth, MD, Anna Mei, BA, Maurizio DiLiberto, PhD, Xiangao Huang, PhD, Scott A Ely, MD, MPH, Ruben Niesvizky, MD, Morton Coleman, MD, Roger N Pearse, MD, PhD, David Jayabalan, B.S.M.S, Lloyd J Old, MD, Selina Chen-Kiang, PhD, Hearn J. Cho, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 785.
https://doi.org/10.1182/blood.V116.21.785.785
Published: 2010
Journal Articles

A Chemical Genetic Analysis of Platelet Activation Identifies An Antithrombotic Allosteric Modulator That Acts through Helix 8 of Par1

Louisa M. Dowal, Derek Sim, James R Dilks, Price Blair, Sarah Beaudry, Bradley Denker, George Koukos, Athan Kuliopulos, Robert Flaumenhaft
Journal: Blood
Blood (2010) 116 (21): 483.
https://doi.org/10.1182/blood.V116.21.483.483
Published: 2010
Journal Articles

In Vitro and In Vivo Inhibition of P-Glycoprotein (ABCB1) by a Novel Non-Substrate Compound: HG-829

Gisela Caceres, Ph.D., Robert W Robey, Ph.D., Lubomir Sokol, MD, PhD, Kathy Rocha McGraw, William J Fulp, Justine Clark, MS, Nicholas J Lawrence, Ph.D., Said Sebti, Ph.D., Susan E. Bates, MD, Alan F. List
Journal: Blood
Blood (2010) 116 (21): 3986.
https://doi.org/10.1182/blood.V116.21.3986.3986
Published: 2010
Journal Articles

The Anti-Malarial Mefloquine Demonstrates Preclinical Activity In Leukemia and Myeloma, and Is Dependent Upon Toll-Like Receptor Signaling for Its Cytotoxicity

Mahadeo A. Sukhai, PhD, Xiaoming Li, PhD, Rose Hurren, Xiaoming Wang, Skrtic Marko, B.Sc., Hong Sun, Marcela Gronda, Ayesh Seneviratne, Dilan Dissanayake, Sue Chow, Rod Bremner, PhD, David Hedley, MD, Mark D. Minden, MD, PhD, Ohashi Pamela, PhD, FRSC, Aaron Schimmer, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 290.
https://doi.org/10.1182/blood.V116.21.290.290
Published: 2010
Journal Articles

MAGE-A3 Inhibits p53 and Promotes Proliferation and Survival in Multiple Myeloma.

Hearn J. Cho, MD, PhD, Anna Mei, Tricia Nardiello, Maurizio DiLiberto, Xiangao Huang, Jennifer E Amengual, MD, Achim Jungbluth, MD, Scott Ely, MD, MPH, Ruben Niesvizky, MD, David S Jayabalan, BSMS, Lloyd Old, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2009) 114 (22): 1795.
https://doi.org/10.1182/blood.V114.22.1795.1795
Published: 2009
Journal Articles

Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor

Medhat Shehata, Susanne Schnabl, Dita Demirtas, Stefanie Tauber, Martin Hilgarth, Martin Bilban, Katrina Vanura, Edit Porpaczy, Christa Fonatsch, Stephan Stilgenbauer, MD, PhD, Josef D. Schwarzmeier, Rainer Hubmann, Alexander Gaiger, Christoph Zielinski, MD, Sauveur-Michel Maira, Carlos Garcia-Echeverria, Wolfgang Hackl, Ulrich Jaeger
Journal: Blood
Blood (2008) 112 (11): 3166.
https://doi.org/10.1182/blood.V112.11.3166.3166
Published: 2008
Journal Articles

Single Oral Administration of KRN383, a Novel Flt3 Inhibitor, Induces Eradication of the Xenograft Tumor Harboring Flt3 Mutation in Mice.

Uichi Nishiyama, Masako Ozai, Rieko Yoshioka, Tetsuya Yoshino, Yuko Ogasawara, Miyuki Kitahori, Eiji Yoshioka, Kazuo Kubo, Yukiko Komeno, MD, Mineo Kurokawa, MD, PhD, Seishi Ogawa, MD, PhD, Shigeru Chiba, MD, PhD, Tatsushi Osawa, PhD, Tomoaki Kuwaki, Hisamaru Hirai, MD, PhD, Atsushi Miwa, PhD
Journal: Blood
Blood (2004) 104 (11): 2545.
https://doi.org/10.1182/blood.V104.11.2545.2545
Published: 2004
Journal Articles

Ki23819 (KRN383•HCl) Inhibits Kinase Activity of Wild Type and Mutant FLT3 Receptor Tyrosine Kinase In Vitro .

Yukiko Komeno, Mineo Kurokawa, Yoichi Imai, Masataka Takeshita, Tomoko Matsumura, Kazuo Kubo, Tetsuya Yoshino, Uichi Nishiyama, Tomoaki Kuwaki, Kinya Kubo, Tatsushi Osawa, Seishi Ogawa, Shigeru Chiba, Atsushi Miwa, Hisamaru Hirai
Journal: Blood
Blood (2004) 104 (11): 1168.
https://doi.org/10.1182/blood.V104.11.1168.1168
Published: 2004
Journal Articles

Protein Palmitoylation Participates in PAR1-Mediated Platelet Activation.

Derek S. Sim, PhD, Blake R. Peterson, PhD, Steffen P. Creaser, PhD, Robert Flaumenhaft, MD PhD
Journal: Blood
Blood (2004) 104 (11): 1560.
https://doi.org/10.1182/blood.V104.11.1560.1560
Published: 2004